Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT) Sees Significant Growth in Short Interest

Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT) saw a large increase in short interest in the month of June. As of June 30th, there was short interest totaling 812 shares, an increase of 7,281.8% from the June 15th total of 11 shares. Based on an average daily volume of 3,083 shares, the days-to-cover ratio is currently 0.3 days. Approximately 0.2% of the company’s stock are sold short.

Institutional Trading of Innovator IBD Breakout Opportunities ETF

Hedge funds have recently added to or reduced their stakes in the company. Osaic Holdings Inc. increased its position in shares of Innovator IBD Breakout Opportunities ETF by 39.7% in the 2nd quarter. Osaic Holdings Inc. now owns 2,102 shares of the company’s stock valued at $77,000 after purchasing an additional 597 shares during the last quarter. Susquehanna International Group LLP lifted its position in shares of Innovator IBD Breakout Opportunities ETF by 42.6% during the 3rd quarter. Susquehanna International Group LLP now owns 26,176 shares of the company’s stock worth $1,020,000 after purchasing an additional 7,817 shares during the last quarter. Finally, Comprehensive Wealth Management LLC lifted its position in shares of Innovator IBD Breakout Opportunities ETF by 122.0% during the 4th quarter. Comprehensive Wealth Management LLC now owns 23,403 shares of the company’s stock worth $850,000 after purchasing an additional 12,859 shares during the last quarter.

Innovator IBD Breakout Opportunities ETF Stock Performance

Shares of BOUT traded down $0.35 during midday trading on Friday, hitting $46.66. The company had a trading volume of 1,926 shares, compared to its average volume of 4,263. The company’s 50-day simple moving average is $46.84 and its 200-day simple moving average is $42.25. The firm has a market capitalization of $16.33 million, a P/E ratio of 28.69 and a beta of 1.03. Innovator IBD Breakout Opportunities ETF has a 1 year low of $35.05 and a 1 year high of $49.41.

About Innovator IBD Breakout Opportunities ETF

The Innovator IBD Breakout Opportunities ETF (BOUT) is an exchange-traded fund that is based on the IBD Breakout Stocks Total Return index. The fund tracks an index of US-listed stocks that are likely to breakout, as determined by technical analysis. Holdings are weighted by a mix of fundamental and technical factors BOUT was launched on Sep 13, 2018 and is managed by Innovator.